These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3704172)

  • 1. Evidence that thioridazine enhances amphetamine-induced stereotypy via anticholinergic activity.
    Robertson A; Campbell C; MacDonald C
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(1):33-40. PubMed ID: 3704172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical neuroleptics clozapine and thioridazine enhance amphetamine-induced stereotypy.
    Robertson A; MacDonald C
    Pharmacol Biochem Behav; 1984 Jul; 21(1):97-101. PubMed ID: 6540455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locomotor stereotypy produced by dexbenzetimide and scopolamine is reduced by SKF 83566, not sulpiride.
    Fritts ME; Mueller K; Morris L
    Pharmacol Biochem Behav; 1998 Jul; 60(3):639-44. PubMed ID: 9678647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy.
    Tschanz JT; Rebec GV
    Pharmacol Biochem Behav; 1988 Nov; 31(3):519-22. PubMed ID: 3251235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of amphetamine-induced locomotor activity and stereotypy in rats by spiroperidol but not by an atypical neuroleptic, thioridazine.
    Bentall AC; Herberg LJ
    Neuropharmacology; 1980 Aug; 19(8):699-703. PubMed ID: 7191488
    [No Abstract]   [Full Text] [Related]  

  • 6. Locomotor stereotypy is produced by methylphenidate and amfonelic acid and reduced by haloperidol but not clozapine or thioridazine.
    Mueller K
    Pharmacol Biochem Behav; 1993 May; 45(1):71-6. PubMed ID: 8100075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic-induced dopamine hyposensitivity.
    Goetz CG; Carvey PM; Tanner CM; Klawans HL
    Life Sci; 1984 Apr; 34(15):1475-9. PubMed ID: 6538629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite effects of sulpiride and metoclopramide on amphetamine-induced stereotypy.
    Robertson A; MacDonald C
    Eur J Pharmacol; 1985 Feb; 109(1):81-9. PubMed ID: 4039669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphetamine-induced locomotor stereotypy in rats is reduced by a D1 but not a D2 antagonist.
    Fritts ME; Mueller K; Morris L
    Pharmacol Biochem Behav; 1997 Dec; 58(4):1015-9. PubMed ID: 9408208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of amphetamine effects by intracerebrally administered anticholinergic agents.
    Costall B; Naylor RJ
    Life Sci I; 1972 Mar; 11(5):239-53. PubMed ID: 4675889
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of phencyclidine and methylphenidate on d-amphetamine-induced behaviors in reserpine pretreated rats.
    Fessler RG; Sturgeon RD; Meltzer HY
    Pharmacol Biochem Behav; 1980 Dec; 13(6):835-42. PubMed ID: 7193876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of phencyclidine on amphetamine stereotypy in rats.
    Balster RL; Chait LD
    Eur J Pharmacol; 1978 Apr; 48(4):445-50. PubMed ID: 565717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of para-chlorophenylalanine on amphetamine-induced locomotion and stereotypy.
    Segal DS
    Brain Res; 1976 Nov; 116(2):267-76. PubMed ID: 135600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticholinergic drugs potentiate dopamine D1 but not D2 antagonists on a conditioned avoidance task in rats.
    Iorio LC; Cohen M; Coffin VL
    J Pharmacol Exp Ther; 1991 Jul; 258(1):118-23. PubMed ID: 1830098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of some atypical neuroleptics on apomorphine-induced behaviors as a measure of their relative potencies in blocking presynaptic versus postsynaptic dopamine receptors.
    Robertson A; MacDonald C
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1639-43. PubMed ID: 2874567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metoclopramide potentiates d-amphetamine-induced hypermotility and stereotypy in rat.
    Howard JL; Pollard GT; Craft RM; Rohrbach KW
    Pharmacol Biochem Behav; 1987 May; 27(1):165-9. PubMed ID: 3615538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha 2-adrenergic antagonists effect on amphetamine-induced behaviors.
    Luttinger D; Durivage ME
    Pharmacol Biochem Behav; 1986 Jul; 25(1):155-60. PubMed ID: 2875469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo electrochemical evidence for an enkephalinergic modulation underlying stereotyped behavior: reversibility by naloxone.
    Broderick PA; Blaha CD; Lane RF
    Brain Res; 1983 Jun; 269(2):378-81. PubMed ID: 6683987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in amphetamine stereotypy following acute lesions of substantia nigra.
    Gonzalez LP
    Life Sci; 1987 Mar; 40(9):899-908. PubMed ID: 3546989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the laterodorsal tegmental nucleus in scopolamine- and amphetamine-induced locomotion and stereotypy.
    Laviolette SR; Priebe RP; Yeomans JS
    Pharmacol Biochem Behav; 2000 Jan; 65(1):163-74. PubMed ID: 10638650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.